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Renal -transplantation has progressed from the 
research stage to become a standard clinical 
procedure. Although still generally limited to large 
medical centers, renal transplants are regularly done 
in over 135 hospitals in the United States. In 1972, 
approximately 2,600 renal transplants were recorded 
in the United States by the Renal Transplant Reg-
istry (I). Approximately 65% of these were cadaver 
donors and 35% living donors. 
The kidney transplant recipient is subject to a 
variety of complications, especially during the early 
post-transplant period. Radionuclide scintiphotog-
raphy has been found to be a valuable method for 
evaluation of renal transplant function and for 
detection of some of the more frequent complica-
tions (2,3,4,5 ). Because of this, scintiphotography 
now has a major role in transplant evaluation. This 
paper will review the radionuclide procedures avail-
able and their current use in evaluation of renal 
transplants. 
Scintigraphic Procedures. The transplanted kid-
ney is routinely placed in the iliac fossa. This loca-
tion allows the kidney, ureter, and bladder to be 
included in the field of view of a standard scintilla-
tion camera. The procedures currently in use are: 
I. kidney and bladder scintigraphy using 131 I-
orthoiodohippurate. 
2. scintigraphy of blood flow distribution fol-
lowed by kidney and bladder imaging using 
99mTc-Sn-DTPA. 
3. scintigraphy using 99mTc-sulfur colloid. 
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4 . scintigraphy combined with transplant 
renogram or other function studies. 
Iodine-131-hippurate scintigraphy. Scintiphoto-
graphs of the kidney and bladder area are obtained 
approximately every 4 minutes for 20 to 30 minutes. 
If the bladder is filled, the patient then voids or the 
catheter is undamped and a post-voiding picture is 
obtained. In a normal study there should be uniform 
maximum concentration in the renal parenchyma at 4 
minutes with excretion into the bladder at 8 minutes 
and decreasing renal concentration by 20 minutes. 
Figure I shows an example of a normal study. 
Perfusion sequence and scintigraphy with 99mTc-
Sn-DTPA . This tracer is excreted exclusively by 
glomerular filtration and is not as rapidly cleared 
from plasma as is hippurate. Sufficient radioactivity 
can be given to visualize the major vessels and renal 
perfusion if rapid sequential scintiphotos are ob-
tained immediately after a bolus injection. A normal 
study of this type is seen in Figure 2. If renal function 
is good, there will be rapid excretion of the tracer and 
subsequent scintiphotos will show the kidney and 
urinary tract as seen in Figure 3. If renal function is 
moderately impaired, however, excretion becomes 
markedly delayed and may not be adequate for 
visualization. Hippurate may still give adequate 
visualization in this case, so that hippurate remains 
the most dependable tracer for routine use, even 
though Tc-Sn-DTPA may in some cases give better 
visualization. 
Scintigraphy with 99mTc-su/fur colloid. Colloidal 
tracers are not normally concentrated in the kidney. 
However, when the changes of chronic rejection 
develop, colloidal tracers are localized to some extent 
IOI 
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Fig I-Norma l scintiphotographic transplant study using "'1-
hippurate. Kidney is seen in first picture and ureter and bladder are 
visualized in later pictures. Time periods are indicated. 
in the kidney and can be demonstrated on scin-
tiphotography. One technique is to use a diverging 
collimator so as to include the bony pelvis but ex-
clude the liver image (6). The concentration in the 
kidney is then compared with that in the bones. An 
example of this study in two separate patients is 
shown in Figure 4. Both patients had mild to 
moderate chronic rejection but well-preserved renal 
function. We have not found this study to be very 
useful since it does not dependably detect acute rejec-
tion and almost all of the transplants eventually 
develop some degree of chronic rejection. 
Scintigraphy combined with renogram or other 
function studies. Scintigraphy with 1311-hippurate 
provides only a crude and semiquantitative measure 
Fig 3-Normal scintigraphic transplant study of excretion phase 
using 99mTc-Sn-DTPA. Kidney, ureter, and bladder are clearly 
seen. 
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Fig 2-Scintiphotos from a transplant perfusion study using 
••mTc-Sn-DTPA. Terminal aorta, iliac arteries, and transplanted 
kidney are seen. 
of renal function. A transplant renogram can be ob-
tained simultaneously and gives an additional 
method of comparing serial studies but is cumber-
some to obtain with standard equipment. If the in-
travenous dose is precisely measured and subsequent 
blood and urine collection are made, the effective 
renal plasma flow may be calculated. The value of 
these additional measurements is not established and 
they are not routinely used. 
Disorders of Transplant Function. The main 
criterion for satisfactory transplant function is an 
adequate urine output. Serious complications are 
usually manifested by a decrease in urine output. 
Fig 4- Scintiphotographs of transplanted kidney after I. V. injec-
tion of 99mTc-sulfur colloid. Two separate patients. On the left, 
concentration is seen in the lumbar spine, pelvis, a nd in the kidney 
in the right iliac fossa. On the right, the kidney concentration is so 
much greater than the bones that pelvis, spine, and upper femur 
are only very faintly seen. 
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Table I gives a list of the common causes of acute 
oliguria in transplant recipients. When oliguria oc-
curs, the cause must be promptly determined as a 
guide to effective treatment. 
Acute tubular necrosis is the most common 
cause of acute oliguria following soon after 
transplantation, especially with cadaver transplants, 
and is completely reversible with adequate treatment. 
If associated with the transplant procedure, this com-
plication occurs within the first 48 hours after sur-
gery. Acute rejection, obstructing clots, and ureteral 
leaks are also common. Arterial and venous occlu-
sion are uncommon, and we have not yet had cortical 
necrosis occur. Lymphocele is a collection of lymph 
adjacent to the transplanted kidney which may occur 
following interruption of lymphatics in that area. 
Lymphoceles usually cause compression or displace-
ment of the ureter and bladder and may produce 
urinary obstruction. They do not occur until after the 
first week and may not develop until six to eight 
months after transplantation. 
Diagnostic Studies for Acute Oliguria. The 
various causes of oliguria listed in Table I cannot be 
differentiated on a clinical basis. Prompt diagnosis is 
obviously of critical importance since the treatment 
for each cause is different and may entail additional 
risk . The order of diagnostic studies used by M . J. V. 
Smith, MD, of the Medical College of Virginia 
Urology Division is given in Table 2 (7) (oral com-
munication, February, 1975). 
The first item on this list, the one-hour biopsy, 
refers to a kidney biopsy obtained at the end of the 
TABLE I 
Causes of Acute Oliguria in Renal Transplant 
Vascular 
Arterial thrombosis 
Venous thrombosis 
Parenchymal 
Acute tubular necrosis 
Acute rejection 
Cortical necrosis 
Ureter 
Clots 
Leaks 
Edema at anastomosis 
Necrosis and retraction 
Bladder 
Leaks or perforations 
General 
Lymphocele 
TABLE 2 
Acute Oliguria in Renal Transplant 
Order of Diagnostic Studies 
1. one-hour biopsy 
2. irrigate catheter 
3. KUB x-ray 
4. scintigram 
5. cystogram 
6. cystoscopy 
a. bulb retrograde 
b. catheter retrograde 
7. arteriography 
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transplant procedure. This may show early evidence 
of acute rejection. The first four steps on this list are 
without risk and often give sufficient diagnostic in-
formation to determine treatment. The subsequent 
procedures should be performed only if necessary 
because of added risk, especially since these patients 
all receive aggressive immunosuppressive therapy. 
Scintigraphic Findings in Transplant Disorders. A 
brief tabulation of the scintigraphic findings in 
transplant disorders is given in Table 3. 
A cute tubular necrosis. With acute tubular 
necrosis the kidney will still concentrate hippurate in 
the renal parenchyma, although the concentration is 
somewhat decreased and maximum concentration is 
delayed. Typically, no excretion into renal pelvis or 
Normal 
TABLE 3 
Scintiphotography of Renal Transplants 
Using "' 1-0rthoiodohippurate 
Uniform maximum concentration in renal 
parenchyma at 4 minutes 
Excretion into bladder by 8 minutes 
Decreasing renal concentration by 20 minutes 
Acute Tubular Necrosis 
Delayed concentration 
No excretion 
Acute Rejection 
Delayed concentration 
Irregular concentration 
Delayed excretion 
Acute Tubular Necrosis with Added Rejection 
Delayed irregular concentration compared 
with baseline 
U reteral Obstruction 
Retention of tracer proximal to obstruction 
Ureteral Leak 
Tracer outside urina ry tract 
Vascular Occlusion- Arterial 
No activity in kidney 
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Fig 5-Selected scintigraphs obtained in a patient with two 
transplanted kidneys studied with 1311-hippurate. Both kidneys are 
seen. The kidney on the patient's right (observer's left) was 
transplanted 15 months previously and is the site of severe chronic 
rejection. The other kidney was inserted one day previously and is 
not functioning because of acute tubular necrosis . 
bladder is visualized. Figure 5 shows pictures selected 
from a series of scintigraphs obtained because of 
severe oliguria one day after transplantation of a sec-
ond kidney into the left iliac fossa. The first kidney 
was inserted 15 months previously on the right side 
and had developed severe chronic rejection. The re-
jected kidney is visualized on the patient's right 
( observer's left) as an area of poor concentration sug-
gesting a small kidney. The new transplant is well 
visualized on the patient's left (observer's right), but 
maximum concentration is definitely delayed and no 
excretion from the kidney is seen even after 30 
minutes. Within a week there was good function of 
the new kidney. 
Rejection. Rejection may be of varying acuteness 
and severity. Hyperacute rejection occurs im-
mediately after transplantation and is associated with 
severe acute inflammatory and vascular changes in 
the kidney. Thrombosis of small vessels occurs, and 
on scintigraphic study the findings may be the same 
as in arterial occlusion. The transplanted kidney must 
always be removed following hyperacute rejection. 
Rejection of less severity may occur at any time fol-
lowing transplantation. This reaction may develop 
quite abruptly and may cause sudden oliguria. On 
scintigraphic study, acute rejection produces delayed 
and sometimes irregular concentration of hippurate. 
Excretion is also delayed or may be absent. Figures 6 
and 7 show scintigraphic studies of a patient who 
received a transplant on 5 December, 1974. The scin-
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Fig 6-Transplant scintigraphic study four days post-transplant 
with good function. 
tigraphic study on 9 December, 1974, (Fig 6) shows 
that the kidney is working quite well. On 11 
December, 1974, the patient developed sudden 
oliguria, and a repeat study on that day is shown in 
Figure 7. Concentration is delayed and there is no ex-
cretion. These findings are compatible with either 
acute tubular necrosis or acute rejection. However, 
the time after transplantation and the demonstration 
of good function two days previously exclude acute 
tubular necrosis resulting from the transplant 
procedure as a cause of the acute oliguria. This 
patient was treated for acute rejection with resulting 
improvement. 
Chronic rejection is associated with delayed con-
centration and delayed excretion as shown in Figure 
8. These findings are not specific for chronic rejection 
since they may occur with other chronic parenchymal 
disease of the kidney. Concentration of colloidal par-
Fig 7- Same patient as Fig. 6 two days later. Acute rejection. 
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Fig 8-Sulfur colloid and hippurate scintigraphs in chronic rejec-
tion. 
ticles can be demonstrated in chronic rejection, but 
this has not been particularly helpful since essentially 
all of the transplants develop some degree of chronic 
rejection. 
Rejection may be of varying degree and may oc-
cur in combination with acute tubular necrosis or 
other disorders. This may be quite difficult to detect. 
However, any deterioration of renal function on scin-
tigraphic study after the first 24 hours usually in-
dicates rejection. It is, therefore, good practice to ob-
tain an initial scintigraphic study at 24 to 48 hours 
after transplantation as a baseline for subsequent 
studies. Changes due to acute tubular necrosis will be 
maximal at 24 hours. 
Ureteral obstruction. The ureter may be 
obstructed early by clots or later by stones or by com-
pressing lesions such as lymphoceles. As long as renal 
parenchymal function remains good there will be 
good concentration of hippurate by the kidney. Scin-
tigraphic study shows accumulation of tracer prox-
imal to the obstruction with delayed or absent excre-
tion into the bladder. An example of partial obstruc-
tion of the upper ureter is shown in Figure 9. 
Ureteral leaks. Extravasation of urine from the 
ureter or from the ureterovesical junction is a com-
mon and serious complication of renal transplanta-
tion. It has occurred in 8% to 30% of several series 
with a mortality rate of 25% to 50%. Ureteral leak is 
readily demonstrable by scintigraphic study, but one 
must be careful to follow the study long enough to 
fully evaluate any unusual appearance. It is also wise 
to obtain post-voiding films to clearly establish blad-
der location. Figure 10 shows several pictures from a 
study obtained one month after transplantation. The 
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Fig 9-Partial ureteral obstruction producing retention in pelvis 
and upper ureter, delayed visualization of bladder. 
patient had increasing serum creatinine, but no local 
signs and was thought to have mild rejection. An ab-
normal collection is seen adjacent to the bladder in 
the early pictures, and at 25 minutes there is a wide 
area of abnormal concentration extending along the 
path of the ureter. The picture at two hours shows the 
radioactivity located in extravasated urine collected 
around the bladder, ureter, and lower pole of the 
kidney. The IO-minute picture also shows some reten-
tion of tracer in the renal pelvis and collecting system 
suggesting mild partial obstruction associated with 
the urinoma. 
Vascular occlusion. With arterial occlusion the 
kidney is not perfused and no tracer is concentrated 
in the kidney. Using 99mTc-pertechnetate or DTPA, 
the major vessels can be visualized and the lack of 
perfusion can be demonstrated as shown in the top 
Fig IO-Progressive urine extravasation from ureterovesical junc-
tion. 
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half of Figure 11. When hippurate is the tracer, scin-
tiphotos over the kidney simply show no concentra-
tion in the renal parenchyma as at the bottom of 
Figure 11. These findings may occur in primary 
arterial occlusion or in hyperacute rejection with 
thrombosis of small vessels. In either case, surgery is 
required for removal of the kidney unless a vascular 
occlusion can be repaired. Venous occlusion, if com-
plete, will block vascular perfusion and is usually fol-
lowed by thrombosis in the arterial supply. However, 
venous thrombosis may partially block vascular flow 
and the kidney may survive after a period of 
decreased function . If there is viable and perfused 
renal tissue still present then there should be some 
concentration of hippurate. It is generally felt, 
though not completely proven, that the absence of 
any demonstrable concentration of hippurate in-
dicates that the kidney is no longer viable and should 
be removed. 
Management of Transplant Oliguria Based on 
Scintigraphic Findings. When oliguria develops in the 
transplant recipient, the results of the scintigraphic 
study together with clinical findings will usually in-
dicate the management to be followed. This is briefly 
summarized in Table 4. If the oliguria develops 
within the first 48 hours and the scintigram shows a 
clear renal image with decreased excretion, manage-
ment for acute tubular necrosis is indicated. If the 
time period is not compatible with acute tubular 
necrosis or if subsequent scintigrams show further 
deterioration, then rejection has developed. If there is 
no renal image with hippurate or technetium, then 
Fig I I-Arterial occlusion . Upper pictures with "mTc-
pertechnetate show terminal aorta and iliac arteries with "cold" 
area over kidney. Lower pictures made with 1311-hippurate show no 
concentration in kidney. 
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TABLE 4 
Hippurate Scintiphotography in Management of 
Acute Oliguria in Renal Transplants 
I. Clear renal image with decreased excretion: 
Conservative Management 
A. If image deteriorates on subsequent study: 
Treat Rejection 
2. No renal image: 
Study with Pertechnetate Bolus 
A. If no perfusion: 
Arteriogram or Surgery 
3. Ureteral obstruction: 
Retrograde or I.V. Urogram or Surgery 
4. Extravasation: 
Retrograde Urogram or Surgery 
surgery is required. An arteriogram can be done if it 
is necessary to differentiate between hyperacute rejec-
tion and arterial occlusion . U reteral obstruction will 
usually be evident on the scintigraph, but further 
diagnostic procedures will be required to determine 
the cause. Extravasation will also be evident on the 
scintigraph, but further studies will be required to 
localize the precise site and extent. In some cases, ex-
travasation can be treated without surgery if infection 
does not develop. 
Conclusions. 
1. Scintiphotography of the kidney and bladder 
using 131 I-hippurate is the basic procedure for 
transplant evaluation. This is a dependable 
method for determining transplant viability 
and function. It is also a dependable method 
for detecting ureteral leak or obstruction, 
provided that renal function is adequate. 
2. Concentration of hippurate indicates that the 
kidney has a blood supply, is viable, and has 
recoverable function. Absence of hippurate 
concentration indicates severe and probably 
irreversible kidney damage. 
3. Scintiphotography with 99mTc-Sn-DTPA 
gives good resolution in normally functioning 
kidneys. With severely impaired renal func-
tion, this tracer is inferior to 131 I-hippurate. 
4. Rapid sequence scintigraphy of the initial cir-
culation using technetium tracers can 
visualize major vessels . and renal perfusion. 
Quantitation and comparison between 
studies are difficult. 
5. A single scintiphotographic study will not 
differentiate between acute tubular necrosis 
and rejection. Serial scintiphotographic 
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studies may indicate rejection if deterioration 
of function is shown to occur later than 24 
hours after transplantation . 
6. Colloidal tracers may concentrate in the 
kidney in chronic rejection. This phenome-
non has not yet been clinically helpful. 
7. The scintigraphic findings in transplant dis-
orders have been reviewed and a schema for 
management based on these findings has been 
presented. 
Figures I and 3 are reprinted from the Journal of Nuclear 
Medicine, Vol. 16, No. 7, with permission of publisher. 
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